CueZen is an AI-based personalization engine for health that seamlessly orchestrates sensor technologies with evidence-based health programs to turn data into actionable interventions. Its platform delivers personalized programs across general wellness, women’s health, metabolic health, cardiovascular care, and sleep disorders, and supports journeys, coaches, nudges, and outcomes. Organizations including Titan, NHS, and Microport use CueZen to increase enrollment, engagement, and adherence. The company notes Singapore uses its platform to evaluate and deliver personalized interventions daily to over 3 million residents for disease prevention. CueZen plans to expand enterprise partnerships and deepen platform capabilities, using new capital to grow sales and AI teams and accelerate product development. Founded in 2021, CueZen describes itself as a global health technology company focused on improving retention, engagement, and revenue opportunities for health enterprises.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

May 2025